866-997-4948(US-Canada Toll Free)

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Published By :

BCC Research

Published Date : Jun 2017

Category :

Biotechnology

No. of Pages : 321 Pages

Report Includes

  • An overview of the global market for next-generation sequencing and its emerging clinical applications.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Examination of the sequencing industry structure for key market segments.
  • Discussion covering the strategies employed by the main companies in the market.
  • Comprehensive company profiles of major players in the field.

Report Scope

The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS-based diagnostics are given for the years 2015, 2016, 2017 and 2022.

This report reviews the main sequencing technologies and explains why genetic variation is important in clinical testing. It then discusses some of the significant research initiatives that impact clinical NGS applications. The main market driving forces are also discussed.

The report examines the markets by test complexity, clinical indication and test purpose. Test complexity refers to the plex level (i.e., the number of genetic markers that can be analyzed within a sample) and coverage (e.g., the extent to which the genome is covered) of the test. Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics, etc.) will be in demand in the future.

The report provides market data and forecasts for NGS diagnostics by specific applications, including those for cancer, cardiovascular diseases, clinical microbiology and infectious diseases, Mendelian disorders, metabolic and immune disorders, neurological disorders, reproductive health, and transplant medicine.

Specific geographic markets are discussed, including North America, Europe, Asia-Pacific, and the rest of the world.

Industry sectors analyzed include sequencing instruments, target enrichment, informatics, clinical laboratory testing services, reproductive health diagnostics, liquid biopsy, immune sequencing, HLA typing, third generation sequencing, and direct to consumer.

More than 200 companies in the clinical NGS industry are profiled in this report.

A summary of the main industry acquisitions and strategic alliances from 2015 through April 2017 are provided, including key alliance trends.

Table of Content

1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown

2: Summary and Highlights

  • Table 1 : Summary Table: Global Clinical Next-Generation Sequencing Market, by Disease Class, Through 2022
  • Figure 1 : Summary Figure: Global Clinical Next-Generation Sequencing Market, by Disease Class, 2015-2022

3: Overview

  • Introduction
  • Clinical NGS Markets
  • Clinical NGS Growth Driving Forces
  • Clinical NGS Applications
  • Clinical NGS Industry

4: Technology Background

  • Importance of DNA
  • Genetic Variation and Analysis
  • Genetic Analysis Technologies
  • Sequencing in Clinical Applications
  • Sequencing Technologies
  • Informatics Technologies
  • Clinical Sequencing Technology Challenges

5: Clinical NGS Initiatives

  • Clinical Next-Generation Sequencing Projects
  • Table 28 : Clinical Next-Generation Sequencing Projects

6: Clinical NGS Applications

  • Introduction
  • Cancer Applications
  • Mendelian Disorders Applications
  • Reproductive Health Applications
  • Microbiology and Infectious Disease Applications
  • Complex Disorders Applications

7: Clinical NGS Industry

  • Introduction
  • NGS Instrument Industry
  • Target Enrichment and Amplification Industry
  • NGS Clinical Informatics Industry
  • NGS Testing Services Industry
  • Reproductive Health Diagnostics Industry
  • Liquid Biopsy Industry
  • Immune Sequencing Industry
  • HLA Typing Industry
  • Third-Generation Sequencing Industry
  • Direct-to-Consumer Genetic Testing Industry

8: Acquisitions and Strategic Alliances

  • Acquisitions
  • Strategic Alliances

9: Clinical NGS Markets

  • Growth Driving Forces
  • Clinical Sequencing Market
  • Clinical NGS Cancer Market
  • NGS Cardiology Diagnostics Markets
  • NGS Mendelian Disorders Diagnostics Markets
  • NGS Metabolic/Immune Disorder Diagnostics Markets
  • NGS Neurology Diagnostics Markets
  • Reproductive Health Markets
  • NGS Microbiology and Infectious Disease Diagnostic Market
  • Transplant Market
  • Geographical Market

10: Patent Review

  • Clinical NGS Patents
  • Clinical NGS Patents by Indication
  • Cell-free DNA Patents
  • Sequencing-Related Patent Issues

11: Company Profiles

  • 3Billion Inc.
  • 10X Genomics, Inc.
  • 23Andme Inc.
  • Adaptive Biotechnologies Inc.
  • Admera Health
  • Agilent Technologies Inc.
  • Alcediag
  • Almac Group Ltd.
  • Amarantus Bioscience Holdings Inc.
  • Ambry Genetics
  • Aperiomics Inc.
  • Appistry Inc.
  • Arup Laboratories
  • Asuragen Inc.
  • Athena Diagnostics Inc.
  • Atreca Inc.
  • Base4 Innovation Ltd.
  • Baylor Miraca Genetics Laboratories Inc.
  • Becton, Dickinson And Co.
  • Bellwether Bio Inc.
  • Berry Genomics Co. Ltd.
  • Bgi Shenzhen
  • Bioarray S.L.
  • Biodesix Inc.
  • Biomarx Inc.
  • Bio-Rad Laboratories Inc.
  • Blueprint Genetics
  • Boreal Genomics
  • Cambridge Epigenetix Ltd.
  • Cancer Genetics
  • Caredx Inc.
  • Caris Life Sciences
  • Cegat Gmbh
  • Cellular Research Inc.
  • Celsee Diagnostics
  • Centogene AG
  • Cergentis BV
  • Chronix Biomedical
  • Circulogene Theranostics
  • Cirina
  • Claritas Genomics Inc.
  • Cofactor Genomics Inc.
  • Combimatrix Corporation
  • Color Genomics
  • Cooper Surgical Inc.
  • Coriell Life Sciences Inc.
  • Correlagen Diagnostics Inc.
  • Cosmosid
  • Counsyl Inc.
  • Courtagen Life Sciences Inc.
  • Cynvenio Biosystems Inc.
  • Cypher Genomics Inc.
  • Danaher Corp.
  • Darui Biotechnology Co. Ltd.
  • Depixus
  • Devyser AB
  • Diagnomics
  • Diploid
  • Directed Genomics Llc
  • Dna Electronics Ltd.
  • Dnanexus Inc.
  • Edico Genome
  • Electronic Biosciences
  • Envision Genomics
  • Epic Sciences
  • Esperite NV
  • Eurofins Genomics
  • Exact Sciences Corporation
  • Exosome Diagnostics Inc.
  • Foundation Medicine Inc.
  • Freenome Inc.
  • Full Genomes Corporation
  • Fusion Genomics Corporation
  • Gatc Biotech AG
  • Genapsys Inc.
  • Gendx BV
  • Gene By Gene Ltd.
  • Genedx Inc.
  • Genepeeks Inc.
  • Genomatix Software Gmbh
  • Genome.One Pty Ltd
  • Genomic Expression
  • Genomic Health Inc.
  • Genome Profiling Llc.
  • Genomnia Srl
  • Genomoncology
  • Genospace
  • Gigagen Inc.
  • Good Start Genetics Inc.
  • Golden Helix
  • Grail
  • Grandomics Biosciences Co. Ltd.
  • Guardant Health Inc.
  • Guardiome
  • Helix Opco Llc
  • Histogenetics Llc.
  • Htg Molecular Diagnostics Inc.
  • Human Longevity Inc.
  • Illumina Inc.
  • Inex Innovations Exchange Pte Ltd
  • Interpace Diagnostics Llc.
  • Invitae
  • Invivoscribe Inc.
  • Irepertoire Inc.
  • Kailos Genetics
  • Karius Inc.
  • Kellbenx Inc.
  • Kew Group Inc.
  • Kingmed Diagnostics Center Co. Ltd.
  • Laboratory Corporation Of America Inc.
  • Laboratory For Molecular Medicine
  • Lasergen Inc.
  • Leucine Rich Bio Pvt. Ltd.
  • Lumenogix Inc.
  • Macrogen Inc.
  • Mapmygenome
  • Maverix Biomics Inc.
  • Mayo Medical Laboratories
  • Medgenome Labs Pvt. Ltd.
  • Medomics Llc.
  • Merck KGAA
  • Mirati Therapeutics
  • Mogene LC
  • Molecular Health Gmbh
  • Molecularmd Corp.
  • Mriglobal Research Institute
  • Myriad Genetics Inc.
  • Nanostring Technologies Inc.
  • Natera Inc.
  • Neogenomics Inc.
  • New England Biolabs
  • Newgene Ltd.
  • New Oncology Gmbh
  • Nipd Genetics
  • N-Of-One Inc.
  • Novartis AG
  • Novogene Corporation
  • Nugen Technologies Inc.
  • Omicia Inc.
  • Omixon Biocomputing KFT
  • Omniseq Llc.
  • Oncodna SA
  • Oncospire Genomics
  • Oneome Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences Of California Inc.
  • Pairnomix Inc.
  • Parabase Genomics
  • Paradigm Diagnostics Inc
  • Parseq Lab S.R.O.
  • Pathway Genomics Corporation
  • Perkinelmer Inc.
  • Personal Genome Diagnostics Inc.
  • Personalis Inc.
  • Pieriandx
  • Population Genetics Technologies Ltd.
  • Portable Genomics Llc
  • Positive Bioscience
  • Predicine Inc.
  • Premaitha Health Plc
  • Prenetics
  • Pressure Biosciences Inc.
  • Preventiongenetics Inc.
  • Qiagen NV
  • Quantapore Inc.
  • Quantum Biosystems Inc.
  • Quantumdx
  • Quest Diagnostics Inc.
  • Real Time Genomics Inc.
  • Resolution Bioscience Inc.
  • Roche Holding AG
  • Sequencing.Com
  • Seven Bridges Genomics Inc.
  • Sistemas Genómicos Sl
  • Softgenetics Llc
  • Sophia Genetics
  • Spera Medical
  • Station X Inc.
  • Strand Life Sciences Pvt. Ltd.
  • Stratec Biomedical AG
  • Stratos Genomics Inc.
  • Supratech Micropath Laboratory & Research Institute Pvt. Ltd.
  • Sure Genomics Inc.
  • Syapse
  • Symbiodx
  • Thermo Fisher Scientific Inc.
  • Transgenomic Inc.
  • Trovagene Inc.
  • Two Pore Guys Inc.
  • Ubiquity Genomics Inc.
  • Vela Diagnostics
  • Wafergen Bio-Systems Inc.
  • Warp Drive Bio Llc.
  • Xcell Biosciences Inc.
  • Yikon Genomics Co. Ltd.
  • Zhejiang Dian Diagnostics Co. Ltd.
  • Zixin Pharmaceutical Industrial Co, Ltd.
  • ZS Genetics Inc.

List of Table

Table 1 : Summary Table: Global Clinical Next-Generation Sequencing Market, by Disease Class, Through 2022
Table 2 : Report Scope
Table 3 : Global Next-Generation Sequencing Diagnostic Market, by Disease Type, Through 2022
Table 4 : Key Technology Drivers for Clinical Next-Generation Sequencing
Table 5 : Clinical Next-Generation Sequencing Market Driving Forces
Table 6 : Clinical Next-Generation Sequencing Application Status
Table 7 : Key Diagnostic Next-Generation Industry Participants by Sector
Table 8 : DNA Chemical Building Blocks
Table 9 : DNA Translation and Transcription
Table 10 : Long-range DNA Structure
Table 11 : Genetic Variant Types
Table 12 : Molecular Diagnostic Technology Platforms
Table 13 : Genetic Testing Evolution
Table 14 : Key Near- to Mid-term Segments for Next-Generation Sequencing Diagnostics
Table 15 : DNA Sequencing Historical Timeline
Table 16 : Sequencing Technology Development, 1990-2020
Table 17 : Cost to Sequence a Single Human Genome, 2001-2017
Table 18 : Sanger Sequencing Summary
Table 19 : Sanger Sequencing Improvements
Table 20 : Next-Generation Sequencing Technologies
Table 21 : Roche Next-Generation Sequencing Workflow
Table 22 : Illumina Next-Generation Sequencing Workflow
Table 23 : Thermo Fisher Next-Generation Sequencing Workflow
Table 24 : Benchtop and Handheld Sequencer Platforms
Table 25 : Next-Generation Sequencing Bioinformatics Workflow
Table 26 : Sequence Annotation Steps
Table 27 : Future Challenges for Implementing Clinical Next-Generation Sequencing
Table 28 : Clinical Next-Generation Sequencing Projects
Table 29 : Clinical Next-Generation Sequencing Near- to Mid-term Applications
Table 30 : Cancer Applications
Table 31 : Mendelian Disorders Applications
Table 32 : Reproductive Health Screening Applications
Table 33 : Ethical Issues Associated with Prenatal and Newborn Screening
Table 34 : Microbiology and Infectious Disease Applications
Table 35 : Complex Disorder Applications
Table 36 : Key Segments within the Next-Generation Sequencing Clinical Industry
Table 37 : Next-Generation Sequencing Instrument Company Summary
Table 38 : Target Enrichment Industry
Table 39 : Next-Generation Sequencing Clinical Informatics Company Positioning
Table 40 : Selected NGS Clinical Testing Laboratories
Table 41 : NGS NIPT Industry
Table 42 : Number of Tests and Market for NIPT, by Region and Company, 2015
Table 43 : Germany NGS-based Non-invasive Prenatal Diagnostic Companies
Table 44 : Fetal Cell NIPT Industry
Table 45 : Liquid Biopsy Company Focus
Table 46 : Example of NGS-based Liquid Biopsy Market Differentiation
Table 47 : Immune System Profiling Industry
Table 48 : NGS-based HLA Typing Industry Competitors
Table 49 : Third-Generation Sequencing Industry
Table 50 : Key Competitors in the Direct-to-Consumer Genetic Testing Industry
Table 51 : Clinical Next-Generation Sequencing Industry Acquisitions, January 2015- April 2017
Table 52 : Clinical Next-Generation Sequencing Strategic Alliances, January 2015- April 2017
Table 53 : Clinical Next-Generation Sequencing Key Market Growth Driving Forces
Table 54 : Global Clinical Sequencing Market, by Indication, Through 2022
Table 55 : Global Clinical NGS Market, by Test Complexity, Through 2022
Table 56 : Global Clinical NGS Market, by Test Purpose, Through 2022
Table 57 : NGS-based Preventive Genetic Screening Tests
Table 58 : Global Clinical NGS Cancer Market, by Indication, Through 2022
Table 59 : Global Clinical NGS Cancer Market, by Test Purpose, Through 2022
Table 60 : Early Cancer Detection
Table 61 : NGS Instrument Company Companion Diagnostics Status
Table 62 : Global Clinical NGS Cancer Market, by Test Complexity, Through 2022
Table 63 : Global Clinical NGS Cardiology Diagnostic Market, by Test Purpose, Through 2022
Table 64 : Dilated Cardiomyopathy Test Providers
Table 65 : Global Clinical NGS Cardiology Diagnostic Market, by Test Complexity, Through 2022
Table 66 : Global Clinical NGS Mendelian Disorder Diagnostic Market, by Test Purpose, Through 2022
Table 67 : Global Clinical NGS Mendelian Disorder Diagnostic Market, by Test Complexity, Through 2022
Table 68 : Global Clinical NGS Metabolic and Immune Disorder Diagnostic Market, by Test Purpose, Through 2022
Table 69 : Multiple Sclerosis Diagnostic Technologies
Table 70 : Global Clinical NGS Metabolic and Immune Disorder Diagnostic Market, by Test Complexity, Through 2022
Table 71 : Global Clinical NGS Neurology Diagnostic Market, by Test Purpose, Through 2022
Table 72 : Global Clinical NGS Neurology Diagnostic Market, by Test Complexity, Through 2022
Table 73 : Global Reproductive Health Market, by Application, Through 2022
Table 74 : Global NIPT Market, by Risk Type, Through 2022
Table 75 : Global Clinical NGS Reproductive Health Market, by Test Complexity, Through 2022
Table 76 : NGS-based Infectious Disease Landscape
Table 77 : Global Clinical NGS Microbiology and Infectious Disease Diagnostic Market, by Test Purpose, Through 2022
Table 78 : Global Clinical NGS Microbiology and Infectious Disease Diagnostic Market, by Test Complexity, Through 2022
Table 79 : NGS in Infectious Disease Diagnostics
Table 80 : Global Clinical NGS Transplant Market, by Analysis Purpose, Through 2022
Table 81 : Global Clinical NGS Transplant Market, by Test Complexity, Through 2022
Table 82 : Global Clinical NGS Transplant Monitoring Market, by Organ Type, Through 2022
Table 83 : Transplant Procedures Performed in the United States, 2015 and 2016
Table 84 : Global Clinical NGS Market, by Region, Through 2022
Table 85 : Global Clinical NGS Cancer Market, by Region, Through 2022
Table 86 : Global Reproductive Health Market, by Region, Through 2022
Table 87 : Global Transplant Market, by Region, Through 2022
Table 88 : Clinical Next-Generation Sequencing Patents, 2005-2015
Table 89 : Clinical Next-Generation Sequencing Patents by Indication, 2005-2015
Table 90 : Cell-free DNA Patents, 2005-2015
Table 91 : Status of Sequencing-Related Patent Disputes
Table 92 : Data Needs
Table 93 : Companies in the Epigenetic Sequencing Industry
Table 94 : Molecular Thyroid Nodule Classifier Test Company Positioning
Table 95 : Sensitivity to Detect Drug Resistant Mutations in Viruses
Table 96 : WaferGen Strategic Alliances

List of Chart

Figure 1 : Summary Figure: Global Clinical Next-Generation Sequencing Market, by Disease Class, 2015-2022

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *